BKYINasdaqServices-Prepackaged SoftwareFiscal year ends December 31
BIO KEY INTERNATIONAL INC
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026
$2.27−0.36 (-13.69%)
Close on Oct 19, 2026
- Market cap
- $2.35M
- P/E (TTM)
- –
- Dividend yield
- –
BIO KEY INTERNATIONAL INC revenue by segment
By business segment
By product or service
| Revenue | Q2 26 | Q1 26 | Q4 25 | Q3 25 | Q2 25 | Q1 25 | Q4 24 | Q3 24 | Q2 24 | Q1 24 | Q4 23 | Q3 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| License [Member] | $1.23M | $1.37M | $600.50K | $917.95K | $806.09K | $1.10M | $1.02M | $1.44M | $774.23K | $1.95M | $577.67K | $950.02K | 64.0% | +52.5% |
| Hardware [Member] | $459.64K | $531.26K | $173.88K | $363.64K | $568.82K | $235.80K | $94.13K | $436.42K | $83.49K | $17.65K | $769.43K | $279.20K | 23.9% | -19.2% |
| Service [Member] | $231.01K | $248.38K | $309.40K | $268.11K | $322.00K | $272.60K | $344.44K | $267.37K | $283.57K | $213.12K | $478.01K | $587.89K | 12.0% | -28.3% |
By region
| Revenue | Q2 26 | Q1 26 | Q4 25 | Q3 25 | Q2 25 | Q1 25 | Q4 24 | Q3 24 | Q2 24 | Q1 24 | Q4 23 | Q3 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EMESA [Member] | $1.04M | $753.83K | $210.67K | $664.08K | $969.44K | $408.13K | $434.61K | $884.43K | $235.99K | $166.26K | $1.18M | $1.02M | 53.9% | +6.8% |
| North America [Member] | $524.79K | $445.34K | $795.98K | $681.70K | $615.26K | $578.28K | $907.52K | $979.92K | $848.68K | $728.13K | $646.69K | $768.70K | 27.3% | -14.7% |
| Asia [Member] | $315.00K | $22.26K | $11.58K | $140.45K | $48.73K | $31.50K | $56.11K | $22.00K | $13.20K | $0 | – | $0 | 16.4% | +546.4% |
| Africa [Member] | $44.41K | $924.10K | $65.56K | $63.48K | $63.48K | $589.25K | $64.04K | $258.46K | $43.42K | $1.29M | $26.01K | $26.01K | 2.3% | -30.0% |
| South America [Member] | – | – | – | – | – | – | – | – | – | $1.29M | $26.01K | $26.01K | – | – |
From the segment and revenue-disaggregation notes of Bio Key International's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.